Form 8-K - Current report:
SEC Accession No. 0001558370-25-010786
Filing Date
2025-08-07
Accepted
2025-08-07 16:30:13
Documents
13
Period of Report
2025-08-05
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20250805x8k.htm   iXBRL 8-K 45395
  Complete submission text file 0001558370-25-010786.txt   161598

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20250805.xsd EX-101.SCH 3986
3 EX-101.DEF tmb-20250805_def.xml EX-101.DEF 2803
4 EX-101.LAB tmb-20250805_lab.xml EX-101.LAB 16544
5 EX-101.PRE tmb-20250805_pre.xml EX-101.PRE 9652
15 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20250805x8k_htm.xml XML 4633
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 251194645
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)